Trial Profile
Evaluation of the effect of nelfinavir on QT intervals at steady-state after twice-daily administration of nelfinavir tablets to healthy volunteers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2009
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- Sponsors Pfizer
- 14 Apr 2009 Planned end date 1 Jun 2006 added as reported by ClinicalTrials.gov
- 22 Nov 2006 New trial record.